Presentations Media coverage

Scandion Oncology was established to address one of the most important problems in modern oncology: the treatment of cancers that have developed resistance to chemotherapy.

Half of all cancer patients fail chemotherapy. This resistance increases mortality and represents a major burden for the health care system.

Presentations

Spotlight

CEO, Nils Brünner says “Scandion Oncology is extremely proud to be listed on Spotlight Stock Market and had it first day of trading shares on Nov. ...
Watch

Scandion Oncology – Sedermeradagen Göteborg 2018

Bolaget Scandion Oncology presenterar på Sedermeradagen i Göteborg den 11 oktober 2018.
Watch

Presentation – Investerarträff Copenhagen, October 4, 2018

Scandion Oncology med vd Nils Brünner presenterar live i Köpenhamn torsdagen den 4. oktober 2018.
Watch

Scandion Oncology presents at Sedermeradagen Malmö 2018

Scandion Oncology på Sedermeradagen i Malmö 2018
Watch

Presentation – Scandion Oncology

Scandion Oncology was formed as a spin-out company from the University of Copenhagen and the research and development company Saniona AB in 2017 for t...
Watch

Market analysis

Long range strategic patient and commercial forecast. The value SCO-101 offer to patients and healthcare providers targeting breat- and colorectal can...
Download

Fact sheet

Factsheet about Scandion Oncology
Download

Media coverage

Scandion Oncology – going on the stock exchange

Watch

Interview – Investerarträff Copenhagen, October 4, 2018

I en intervju med Finwire.tv berättar CEO Nils Brünner om bolaget, marknaden och planerna framåt.
Watch